Integrin αVβ3 silencing sensitizes malignant glioma cells to temozolomide by suppression of homologous recombination repair.

Saved in:
Bibliographic Details
Title: Integrin αVβ3 silencing sensitizes malignant glioma cells to temozolomide by suppression of homologous recombination repair.
Authors: Christmann M; Department of Toxicology, University Medical Center Mainz, D-55131 Mainz, Germany., Diesler K; Department of Toxicology, University Medical Center Mainz, D-55131 Mainz, Germany., Majhen D; Laboratory for Cell Biology and Signaling, Division of Molecular Biology, Ruđer Bošković Institute, HR-10000 Zagreb, Croatia., Steigerwald C; Department of Toxicology, University Medical Center Mainz, D-55131 Mainz, Germany., Berte N; Department of Toxicology, University Medical Center Mainz, D-55131 Mainz, Germany., Freund H; Department of Toxicology, University Medical Center Mainz, D-55131 Mainz, Germany., Stojanović N; Laboratory for Cell Biology and Signaling, Division of Molecular Biology, Ruđer Bošković Institute, HR-10000 Zagreb, Croatia., Kaina B; Department of Toxicology, University Medical Center Mainz, D-55131 Mainz, Germany., Osmak M; Laboratory for Cell Biology and Signaling, Division of Molecular Biology, Ruđer Bošković Institute, HR-10000 Zagreb, Croatia., Ambriović-Ristov A; Laboratory for Cell Biology and Signaling, Division of Molecular Biology, Ruđer Bošković Institute, HR-10000 Zagreb, Croatia., Tomicic MT; Department of Toxicology, University Medical Center Mainz, D-55131 Mainz, Germany.
Source: Oncotarget [Oncotarget] 2017 Apr 25; Vol. 8 (17), pp. 27754-27771.
Publication Type: Journal Article
Journal Info: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1949-2553
DOI:10.18632/oncotarget.10897